Evolutionary Action Score Identifies a Subset of TP53 Mutated Myelodysplastic Syndrome with Favorable Prognosis, Rashmi Kanagal-Shamanna, Guillermo Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb Class, Christopher Benton, Elias Jabbour, Kelly Chien, Rajyalakshmi Luthra, Carlos Bueso-Ramos, Tapan Kadia, Michael Andreeff, Nicholas Short, Naval Daver, Mark Routbort, Joseph Khoury, Keyur Patel, Irene Ganan-Gomez, Yue Wei, Gautam Borthakur, Farhad Ravandi, Kim-Anh Do, Kelly Soltysiak, Olivier Lichtarge, L. Medeiros, Hagop Kantarjian, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS

Outcomes of Acute Myeloid Leukemia with Myelodysplasia Related Changes depend on diagnostic criteria and therapy, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Caleb Class, Koji Sasaki, Farhad Ravandi, Jorge Cortes, Naval Daver, Koichi Takahashi, Nicholas Short, Courtney DiNardo, Elias Jabbour, Gautam Borthakur, Kiran Naqvi, Ghayas Issa, Marina Konopleva, Joseph Khoury, Mark Routbort, Sherry Pierce, Kim Anh, Carlos Bueso-Ramos, Keyur Patel, Hagop Kantarjian, Guillermo Garcia-Manero, Tapan Kadia
Scholarship and Professional Work – COPHS

Long-Term Follow up of a Randomized Phase 2 Study of Low-Dose Decitabine Versus Low-Dose Azacitidine in Lower-Risk Myelodysplastic Syndromes, Guillermo Montalban-Bravo, Elias Jabbour, Caleb Class, Nicholas Short, Rashmi Kanagal-Shamanna, Tapan Kadia, Gautam Borthakur, Naveen Pemmaraju, Koji Sasaki, Zeev Estrov, Jorge Cortes, Farhad Ravandi, Yesid Alvarado, Rami Komrokji, Mikkael Sekeres, David Steensma, Amy DeZern, Gail Roboz, Hui Yang, Hagop Kantarjian, Guillermo Garcia-Manero
Scholarship and Professional Work – COPHS